These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 7692469

  • 1. [FK506 and kifunensine, new immunomodulators of microbial origin].
    Izumi S, Okuhara M.
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1800-12. PubMed ID: 7692469
    [No Abstract] [Full Text] [Related]

  • 2. Calcineurin mutants render T lymphocytes resistant to cyclosporin A.
    Zhu D, Cardenas ME, Heitman J.
    Mol Pharmacol; 1996 Sep; 50(3):506-11. PubMed ID: 8794888
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?
    Schreier MH, Baumann G, Zenke G.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):502-7. PubMed ID: 7679818
    [No Abstract] [Full Text] [Related]

  • 4. Calcineurin: not just a simple protein phosphatase.
    Guerini D.
    Biochem Biophys Res Commun; 1997 Jun 18; 235(2):271-5. PubMed ID: 9199180
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. FK506 in bone marrow transplantation.
    Hemenway C.
    Blood; 1995 Nov 01; 86(9):3611-2. PubMed ID: 7579473
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
    Bierer BE, Jin YJ, Fruman DA, Calvo V, Burakoff SJ.
    Transplant Proc; 1991 Dec 01; 23(6):2850-5. PubMed ID: 1721296
    [No Abstract] [Full Text] [Related]

  • 11. Biology of cyclosporin A and FK506.
    Bierer BE.
    Prog Clin Biol Res; 1994 Dec 01; 390():203-23. PubMed ID: 7536944
    [No Abstract] [Full Text] [Related]

  • 12. Depletion of the mature CD4+8- thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities.
    Koprak S, Sirotina A, Ok H, Dumont FJ.
    Transplantation; 1996 Mar 27; 61(6):926-32. PubMed ID: 8623162
    [Abstract] [Full Text] [Related]

  • 13. [A second target of cyclosporin A and FK506].
    Matsuda S, Koyasu S.
    Tanpakushitsu Kakusan Koso; 2000 Aug 27; 45(11):1823-31. PubMed ID: 10936966
    [No Abstract] [Full Text] [Related]

  • 14. FK-506--a novel immunosuppressant.
    Parsons WH, Sigal NH, Wyvratt MJ.
    Ann N Y Acad Sci; 1993 Jun 23; 685():22-36. PubMed ID: 7689805
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FK506 inhibits human lymphocyte migration and the production of lymphocyte chemotactic factors in liver allograft recipients.
    Adams DH, Liu Q.
    Hepatology; 1996 Jun 23; 23(6):1476-83. PubMed ID: 8675167
    [Abstract] [Full Text] [Related]

  • 19. Pharmacodynamic monitoring of immunosuppressive drugs.
    Yatscoff RW, Langman LJ, LeGatt DF.
    Transplant Proc; 1996 Dec 23; 28(6):3013-5. PubMed ID: 8962169
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.